Soumi Gupta

972 total citations
23 papers, 731 citations indexed

About

Soumi Gupta is a scholar working on Virology, Infectious Diseases and Genetics. According to data from OpenAlex, Soumi Gupta has authored 23 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 11 papers in Infectious Diseases and 7 papers in Genetics. Recurrent topics in Soumi Gupta's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (9 papers) and Virus-based gene therapy research (5 papers). Soumi Gupta is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (9 papers) and Virus-based gene therapy research (5 papers). Soumi Gupta collaborates with scholars based in United States, Switzerland and Belgium. Soumi Gupta's co-authors include Christos J. Petropoulos, Wei Huang, Signe Fransen, Robert M. Danovich, Daria J. Hazuda, Marc Witmer, Michael D. Miller, Joy Olbertz, Haoling H. Weng and Kevin Larimore and has published in prestigious journals such as Journal of Virology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Soumi Gupta

23 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Soumi Gupta United States	15	397	395	270	166	107	23	731
Miranda S. Moore United States	12	92 0.2×	105 0.3×	700 2.6×	26 0.2×	146 1.4×	41	1.0k
Shahzada Khan United States	14	91 0.2×	79 0.2×	228 0.8×	11 0.1×	175 1.6×	22	689
J L Martin United States	7	827 2.1×	772 2.0×	246 0.9×	44 0.3×	330 3.1×	8	1.1k
Naoto Mamiya Japan	9	149 0.4×	104 0.3×	188 0.7×	27 0.2×	67 0.6×	17	387
Seema Desai United States	11	183 0.5×	260 0.7×	113 0.4×	6 0.0×	236 2.2×	20	689
Nicola Mongiardo Italy	10	178 0.4×	230 0.6×	84 0.3×	10 0.1×	192 1.8×	19	500
Malgorzata Simm United States	15	187 0.5×	339 0.9×	158 0.6×	37 0.2×	171 1.6×	26	621
Shahin Ranjbar United States	15	255 0.6×	184 0.5×	228 0.8×	4 0.0×	169 1.6×	24	621
Elisabetta Ugolotti Italy	12	88 0.2×	17 0.0×	104 0.4×	38 0.2×	65 0.6×	33	353
Geza Paukovics Australia	16	269 0.7×	502 1.3×	133 0.5×	4 0.0×	190 1.8×	17	930

Countries citing papers authored by Soumi Gupta

Since Specialization

Citations

This map shows the geographic impact of Soumi Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soumi Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soumi Gupta more than expected).

Fields of papers citing papers by Soumi Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soumi Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soumi Gupta. The network helps show where Soumi Gupta may publish in the future.

Co-authorship network of co-authors of Soumi Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Soumi Gupta. A scholar is included among the top collaborators of Soumi Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soumi Gupta. Soumi Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robinson, Tara M., Kathryn Patton, Joshua Henshaw, et al.. (2024). Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A. Molecular Therapy. 32(7). 2052–2063. 11 indexed citations

Fong, Sylvia, Tara M. Robinson, Jonathan F. Day, et al.. (2022). Interim 52-week analysis of immunogenicity to the vector capsid and transgene-expressed human FVIII in GENEr8-1, a phase 3 clinical study of valoctocogene roxaparvovec, an AAV5-mediated gene therapy for hemophilia A. Journal of Hepatology. 77. S540–S540. 2 indexed citations

Yang, Fan, Kathryn Patton, Brian Long, et al.. (2021). Validation of an IFN-gamma ELISpot assay to measure cellular immune responses against viral antigens in non-human primates. Gene Therapy. 29(1-2). 41–54. 21 indexed citations

Zhou, Huiyu, Johanna R. Abend, Joy Olbertz, et al.. (2021). Achieving efficacy in subjects with sustained pegvaliase-neutralizing antibody responses. Molecular Genetics and Metabolism. 134(3). 235–242. 4 indexed citations

Henshaw, Joshua, Soumi Gupta, Joy Olbertz, et al.. (2021). Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria. Clinical and Translational Science. 14(5). 1894–1905. 14 indexed citations

Larimore, Kevin, Roberto Zori, Gillian Shepherd, et al.. (2019). Depletion of interfering IgG and IgM is critical to determine the role of IgE in pegvaliase-associated hypersensitivity. Journal of Immunological Methods. 468. 20–28. 7 indexed citations

Thomas, Janet A., Harvey L. Levy, Stephen Amato, et al.. (2018). Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM). Molecular Genetics and Metabolism. 124(1). 27–38. 134 indexed citations

Gupta, Soumi, Cary O. Harding, Gillian Shepherd, et al.. (2018). Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. EBioMedicine. 37. 366–373. 59 indexed citations

Lathouwers, Erkki, Soumi Gupta, Mojgan Haddad, et al.. (2015). Trends in Darunavir Resistance-Associated Mutations and Phenotypic Resistance in Commercially Tested United States Clinical Samples Between 2006 and 2012. AIDS Research and Human Retroviruses. 31(6). 628–635. 7 indexed citations

10.

Fransen, Signe, et al.. (2012). Substitutions at Amino Acid Positions 143, 148, and 155 of HIV-1 Integrase Define Distinct Genetic Barriers to Raltegravir Resistance In Vivo. Journal of Virology. 86(13). 7249–7255. 31 indexed citations

11.

Hatano, Hiroyu, Harry Lampiris, Signe Fransen, et al.. (2010). Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(4). 389–393. 62 indexed citations

12.

Gupta, Soumi, Signe Fransen, Ellen E. Paxinos, et al.. (2010). Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance. Antimicrobial Agents and Chemotherapy. 54(5). 1973–1980. 43 indexed citations

13.

Fransen, Signe, Soumi Gupta, Robert M. Danovich, et al.. (2009). Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways. Journal of Virology. 83(22). 11440–11446. 140 indexed citations

14.

Goodsell, Amanda, Fengmin Zhou, Soumi Gupta, et al.. (2007). β7‐integrin‐independent enhancement of mucosal and systemic anti‐HIV antibody responses following combined mucosal and systemic gene delivery. Immunology. 123(3). 378–389. 19 indexed citations

15.

Hu, Zixin, Hiroyu Hatano, Sarah P. Hammond, et al.. (2007). Virologic Characterization of HIV Type 1 With a Codon 70 Deletion in Reverse Transcriptase. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(5). 494–500. 7 indexed citations

16.

Gupta, Soumi, Fengmin Zhou, Catherine E. Greer, et al.. (2006). Antibody Responses against HIV in Rhesus Macaques following Combinations of Mucosal and Systemic Immunizations with Chimeric Alphavirus-Based Replicon Particles. AIDS Research and Human Retroviruses. 22(10). 993–997. 13 indexed citations

17.

Gupta, Soumi, Christian M. Leutenegger, Gregg A. Dean, & Ellen E. Sparger. (2006). Construction and Characterization of Feline Immunodeficiency Virus Proviral Mutants That Coexpress Interferon Gamma and Green Fluorescent Protein. AIDS Research and Human Retroviruses. 22(4). 342–349. 3 indexed citations

18.

Parkin, Neil, Soumi Gupta, Colombe Chappey, & Christos J. Petropoulos. (2005). The K101P and K103R/V179D Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nonnucleoside Reverse Transcriptase Inhibitors. Antimicrobial Agents and Chemotherapy. 50(1). 351–354. 33 indexed citations

19.

Gupta, Soumi, Janani Ramesh, Paul A. Luciw, et al.. (2005). Characterization of Human Immunodeficiency Virus Gag-Specific Gamma Interferon-Expressing Cells following Protective Mucosal Immunization with Alphavirus Replicon Particles. Journal of Virology. 79(11). 7135–7145. 34 indexed citations

20.

Soenawan, Elawati, Indresh K. Srivastava, Soumi Gupta, et al.. (2003). Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant. Vaccine. 22(11-12). 1553–1563. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact